A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Dravet Syndrome

In brief

The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.

Key facts

Study ID
NCT06872125
Run by
Stoke Therapeutics, Inc
People needed
170
Starts
2025-06-04
Expected to finish
2028-10-01
Last updated by the study team
2026-08-05

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.